Literature DB >> 10906146

Cdk2-dependent phosphorylation and functional inactivation of the pRB-related p130 protein in pRB(-), p16INK4A(+) tumor cells.

L Cheng1, F Rossi, W Fang, T Mori, D Cobrinik.   

Abstract

The retinoblastoma family proteins pRB, p107, and p130 are phosphorylated and released from E2Fs in the late G(1) phase of the cell cycle. This phosphorylation is thought to contribute to the derepression of E2F-responsive genes and to be mediated, in part, by Cdk4 and Cdk6. Evidence that Cdk4/6 activity is inhibited by p16(INK4A) in most pRB(-) cells suggests that p107 and p130 may be underphosphorylated and remain associated with E2Fs during G(1)-S progression in cells that lack pRB. To examine this, we evaluated the cell cycle-dependent phosphorylation and E2F binding abilities of p107 and p130 in pRB(-), p16(+) Saos-2 osteosarcoma cells. p130, but not p107, was phosphorylated and released from E2F-4 in late G(1) and S phase cells, although p130 phosphorylation differed qualitatively in these and other pRB(-), p16(+) cells as compared with pRB(+), p16(-) cell types. p130 phosphorylation occurred in the absence of cyclin D-Cdk4/6 complexes, coincided with cyclin E- and Cdk2-associated kinase activity, and was prevented by expression of dominant negative Cdk2. Moreover, dominant negative Cdk2 prevented the dissociation of endogenous p130-E2F-4 complexes and inhibited E2F-4-dependent transcription. These findings show that p130 can be phosphorylated and functionally inactivated in a Cdk2-dependent process, and they highlight the involvement of distinct Cdks in the regulation of different pRB family proteins.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10906146     DOI: 10.1074/jbc.M005707200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Pocket protein p130/Rb2 is required for efficient herpes simplex virus type 1 gene expression and viral replication.

Authors:  G L Ehmann; H A Burnett; S L Bachenheimer
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Phosphorylation-dependent and -independent functions of p130 cooperate to evoke a sustained G1 block.

Authors:  K Hansen; T Farkas; J Lukas; K Holm; L Rönnstrand; J Bartek
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

3.  Peroxisome proliferator-activated receptor β/δ cross talks with E2F and attenuates mitosis in HRAS-expressing cells.

Authors:  Bokai Zhu; Combiz Khozoie; Moses T Bility; Christina H Ferry; Nicholas Blazanin; Adam B Glick; Frank J Gonzalez; Jeffrey M Peters
Journal:  Mol Cell Biol       Date:  2012-04-02       Impact factor: 4.272

4.  Inhibition of aldose reductase prevents growth factor-induced G1-S phase transition through the AKT/phosphoinositide 3-kinase/E2F-1 pathway in human colon cancer cells.

Authors:  Kota V Ramana; Ravinder Tammali; Satish K Srivastava
Journal:  Mol Cancer Ther       Date:  2010-03-30       Impact factor: 6.261

5.  Biomarkers in Osteosarcoma.

Authors:  Colin Kong; Marc F Hansen
Journal:  Expert Opin Med Diagn       Date:  2009-01-01

6.  The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCF(Skp2).

Authors:  Donato Tedesco; Jiri Lukas; Steven I Reed
Journal:  Genes Dev       Date:  2002-11-15       Impact factor: 11.361

7.  Scatter factor/hepatocyte growth factor stimulation of glioblastoma cell cycle progression through G(1) is c-Myc dependent and independent of p27 suppression, Cdk2 activation, or E2F1-dependent transcription.

Authors:  Kevin A Walter; Mir Ahamed Hossain; Carey Luddy; Nidhi Goel; Thomas E Reznik; John Laterra
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

8.  Combination effect of oncolytic adenovirotherapy and TRAIL gene therapy in syngeneic murine breast cancer models.

Authors:  W Guo; H Zhu; L Zhang; J Davis; F Teraishi; J A Roth; C Stephens; J Fueyo; H Jiang; C Conrad; B Fang
Journal:  Cancer Gene Ther       Date:  2006-01-01       Impact factor: 5.987

9.  Casein kinase II motif-dependent phosphorylation of human papillomavirus E7 protein promotes p130 degradation and S-phase induction in differentiated human keratinocytes.

Authors:  Nicholas J Genovese; N Sanjib Banerjee; Thomas R Broker; Louise T Chow
Journal:  J Virol       Date:  2008-03-05       Impact factor: 5.103

10.  Human papillomavirus type 16 E7 oncoprotein can induce abnormal centrosome duplication through a mechanism independent of inactivation of retinoblastoma protein family members.

Authors:  Stefan Duensing; Karl Münger
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.